A prospective randomized controlled trial. Usefulness of the hepaticoplasty to prevent postoperative cholangitis after pancreaticoduodenectomy.

A prospective randomized controlled trial. Usefulness of the hepaticoplasty to prevent postoperative cholangitis after pancreaticoduodenectomy. - A prospective randomized controlled trial. Usefulness of the hepaticoplasty to prevent postoperative cholangitis after pancreaticoduodenectomy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007210

Enrollment

Registered

2012-02-03

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary disease required pancreaticoduodenectomy

Interventions

Hepaticojejunostomy with hepaticoplasty. Hepaticojejunostomy without hepaticoplasty.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The cases of pancreaticoduodenectomy for periampullary disease.

Exclusion criteria

Exclusion criteria: Young children. Pregnancy. Not agree this study.

Design outcomes

Primary

Measure	Time frame
Postoperative cholangitis	—

Countries

Japan

Contacts

Public ContactMasahide Hiyoshi

Miyazaki University School of Medicine Department of Surgical Oncology and Regulation of Organ Function

mhiyoshi@med.miyazaki-u.ac.jp0985-85-9284

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026